NCT03668158

Brief Summary

The purpose of this study is to establish molecular subtyping of HCC.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 12, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

November 20, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

October 24, 2018

Status Verified

October 1, 2018

Enrollment Period

1.4 years

First QC Date

September 10, 2018

Last Update Submit

October 23, 2018

Conditions

Hepatocellular Carcinoma

Outcome Measures

Primary Outcomes (1)

  • recurrence rate

    2 years

Study Arms (2)

recurrent HCC

recurrent HCC after LT

non-recurrent HCC

non- recurrent HCC after LT

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalization patient

You may qualify if:

  • Liver transplantation due to HCC within Hangzhou criteria

You may not qualify if:

  • Liver transplantation due to HCC beyond Hangzhou criteria Liver transplantation due to other disease except HCC Multiple organ transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 10, 2018

First Posted

September 12, 2018

Study Start

November 20, 2018

Primary Completion

May 1, 2020

Study Completion

July 1, 2020

Last Updated

October 24, 2018

Record last verified: 2018-10